. . . . . . . . . . . . "[Our Egr-1/TRAIL adenoviral gene product may offer a novel `one-two punch` tumor therapy for cervical cancers not only by potentiating radiation treatment but also by preserving p53 defect-specific tumor killing of the oncolytic adenovirus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2014-02-25"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2014-10-02T12:34:12+02:00"^^ . . . . . . . . . . . "v2.1.0.0" . "v2.1.0" .